RAP1A and neoplasm: Mechanistically, ARHGEF12 E620K mutation upregulated ITGA6 expression through Rap1 signaling pathway activation and promoted tumor-derived ITGA6-high exosome formation, which were preferentially uptaken by ovarian fibroblasts.